This inventor holds 2 USPTO granted patents. Top assignee: Ngm Biopharmaceuticals, Inc.. Active years: 2023-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2025
Title: Kevin James Paavola: Innovator in Biopharmaceuticals
Introduction
Kevin James Paavola is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of biopharmaceuticals, particularly through his innovative work on ILT3-binding agents. With a total of 2 patents to his name, Paavola continues to push the boundaries of medical science.
Latest Patents
Paavola's latest patents focus on ILT3-binding agents and methods of use thereof. The present disclosure provides binding agents, such as antibodies, that specifically bind ILT3, including human ILT3. It also includes compositions comprising the binding agents and methods of their use. Additionally, the disclosure provides related polynucleotides and vectors encoding the binding agents and cells comprising the binding agents.
Career Highlights
Kevin James Paavola is currently employed at Ngm Biopharmaceuticals, Inc. His work at this company has allowed him to collaborate with other talented professionals in the field, further enhancing his contributions to biopharmaceutical research.
Collaborations
Some of his notable coworkers include Suzanne Christine Crawley and Jer-Yuan Hsu. Their collaborative efforts have played a crucial role in advancing the research and development of innovative biopharmaceutical solutions.
Conclusion
Kevin James Paavola is a distinguished inventor whose work in biopharmaceuticals has the potential to impact medical treatments significantly. His patents and collaborations reflect his commitment to advancing healthcare through innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile